PHH — Park Ha Biological Technology Co Income Statement
0.000.00%
Last trade - 00:00- $12.73m
- $12.54m
- CNY2.38m
Annual income statement for Park Ha Biological Technology Co, fiscal year end - October 31st, CNY millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.931 | 1.92 | 2.46 | 2.38 |
| Cost of Revenue | ||||
| Gross Profit | 0.62 | 1.41 | 2.15 | 2.19 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 1.43 | 1.72 | 1.28 | 1.59 |
| Operating Profit | -0.501 | 0.197 | 1.18 | 0.794 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.485 | 0.19 | 1.18 | 0.793 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.485 | 0.191 | 0.852 | 0.479 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.485 | 0.191 | 0.852 | 0.479 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.485 | 0.191 | 0.852 | 0.479 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.019 | 0.007 | 0.033 | 0.019 |